{"title":"Trelleborg invests in its biopharmaceutical manufacturing site in Europe","authors":"","doi":"10.12968/s1350-4789(23)70022-6","DOIUrl":null,"url":null,"abstract":"The Healthcare & Medical business of engineered polymer technology company Trelleborg AB is making a substantial investment in its biopharmaceutical manufacturing site in Europe.","PeriodicalId":101151,"journal":{"name":"Sealing Technology","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sealing Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/s1350-4789(23)70022-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Healthcare & Medical business of engineered polymer technology company Trelleborg AB is making a substantial investment in its biopharmaceutical manufacturing site in Europe.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
